MD, FACS is Attending Surgeon and Director of Retina Research of Wills Eye Hospital and Professor of Ophthalmology at Thomas Jefferson University. He maintains special interests in macular diseases, diabetic retinopathy, surgical retinal diseases and clinical trials investigating new treatments for vitreoretinal diseases including gene and cell therapies and new surgical drug delivery devices and techniques. His experience includes collaborative translational and clinical trial clinical research with expertise in study design, methodological testing, data analyses, surgical instrumentation and procedure development, execution and communication of these studies and their study results. He is the recent President of The Retina Society.

Through the Wills Eye Hospital Retina Fellowship he has mentored over 60 retina fellows and international research trainees. He has been Study Chair, Steering Committee Member or Principal Investigator of over 50 clinical trials. Dr. Ho has served on the US FDA Ophthalmic Device Panel, AAO Ophthalmic Retina Technology Assessment Committee, AAO Retina Measures Group, AAO IRIS Registry Committee and is past Chair of the AAO Retina Subspecialty Days and Vail Vitrectomy meetings. He serves on the Executive Committee of the Retina Society and the board of the American Diabetes Association of Greater Philadelphia. Dr. Ho has authored over 250 peer reviewed publications and several textbooks and is Editor-in-Chief of Current Opinion in Ophthalmology and Chief Medical Editor of Retina Today. He is a perennial awardee of national and regional Top Doctors awards and has been named to The Ophthalmologist Power 100 most influential eye specialists in the world on multiple occasions, most recently 2020.